Gut Health & Microbiome: A Complete Guide After 40

The gut microbiome is one of the most clinically underused diagnostic tools in preventive medicine. Most of my patients over 40 have never had a microbiome analysis. Yet when we measure it — looking at specific markers like butyrate producers, Akkermansia levels, LPS burden, and dysbiosis patterns — we almost always find something actionable.

This guide consolidates what I look at clinically, why each marker matters, and what you can actually do about it. Not a list of supplements to buy — a framework for understanding what’s happening in your gut and why it drives so many of the symptoms patients dismiss as “getting older.”

Why Gut Health Matters More After 40

The human gastrointestinal tract contains trillions of bacteria performing functions your body depends on: fermenting dietary fiber into fuel, producing neurotransmitters, regulating immune responses, and maintaining the gut barrier that separates your bloodstream from the contents of your intestine. When this ecosystem is healthy, most of these processes are invisible. When it degrades — through antibiotic use, diet changes, stress, or simple aging — the effects show up everywhere: fatigue, brain fog, weight gain, insulin resistance, and chronic low-grade inflammation.

After 40, the microbiome naturally loses diversity. Specific protective strains decline — particularly Akkermansia muciniphila and butyrate-producing bacteria. The tight junctions between intestinal cells loosen. Inflammatory signals from gut bacteria (LPS) leak into circulation. None of this happens overnight, but it compounds, and it’s measurable long before it becomes a diagnosed disease.

The Key Markers We Measure

Butyrate

Short-chain fatty acid produced by bacterial fermentation of fiber. Primary fuel for the intestinal wall. Low levels correlate with IBD, insulin resistance, and obesity.

LPS (Lipopolysaccharides)

Fragments of bacterial cell walls. At normal levels (0.2 ng/ml) they provide immune training. Elevated (>1 ng/ml) signals gut permeability and drives systemic inflammation.

Akkermansia muciniphila

Barrier-strengthening bacterium. Should make up 1–4% of a healthy microbiome. Declines with age and ultra-processed food intake.

Dysbiosis / SIBO risk

Bacterial imbalance between colon and small intestine. When bacteria overgrow in the wrong location, nutrient absorption is disrupted and toxin load increases.

Butyrate: The Intestinal Wall’s Primary Fuel

Butyrate is produced in the colon when bacteria ferment dietary fiber. It is the preferred energy source for colonocytes — the cells lining your intestinal wall. Without adequate butyrate, these cells become underfed, the gut barrier weakens, and inflammatory conditions take hold.

The clinical evidence for butyrate is specific. At 4 g/day for 8 weeks, oral butyrate supplementation shows measurable recovery in patients with inflammatory bowel disease. People with normal body weight consistently have more butyrate-producing bacteria than those with insulin resistance or metabolic syndrome. Transplanting butyrate-producing bacteria into patients with obesity-related complications produces marked improvement in metabolic markers.

Butyrate deficiency produces a recognizable pattern of symptoms:

• Epigastric pain and bloating
• Indigestion and flatulence
• Gut wall inflammation
• Insulin resistance
• Tendency toward weight gain and atherosclerotic risk

How to raise butyrate levels naturally

The most direct route is dietary fiber — when you eat fiber, your gut bacteria ferment it and produce butyrate. Whole grains, vegetables, and legumes are the substrate. Adding ghee or butter provides direct butyrate as a short-chain fatty acid while also feeding the bacteria that produce it. Yogurt supports the bacterial populations involved in fermentation. The practical prescription: more fiber, less ultra-processed food, and cooking with ghee or butter over refined seed oils.

Metabolic connection: Butyrate has documented extraintestinal effects beyond the gut — improved insulin sensitivity, reduced cholesterol synthesis, and protection against atherosclerotic disease. This is why gut health and cardiovascular risk are more connected than most patients expect.

LPS and Gut Inflammation:

When the Barrier Fails

Lipopolysaccharides (LPS) are structural components of the outer membrane of gram-negative bacteria. In a healthy gut, they stay inside the intestinal lumen, providing baseline immune system training. The intestinal cells form tight junctions that prevent these molecules from crossing into the bloodstream. Normal LPS levels run around 0.2 ng/ml.

When the gut barrier breaks down — through dysbiosis, chronic stress, or inflammatory diet — those tight junctions loosen. LPS leaks through. In patients with inflammatory bowel disease or Crohn’s disease, measured LPS levels rise to 1–2 ng/ml. At those concentrations, LPS triggers a systemic immune response: chronic low-grade inflammation, insulin resistance, and accelerated cardiovascular risk.

Elevated LPS is associated with a recognizable cluster of conditions:

• Obesity and insulin resistance
• Arteriosclerosis and increased stroke risk
• IBD and Crohn’s disease
• Cellular damage and polyp formation

The approach to reducing LPS burden is the same as improving gut barrier integrity generally: increase fiber and polyphenol intake, reduce ultra-processed foods, and support the bacterial species — particularly Akkermansia — that maintain the mucosal lining.

Akkermansia: The Barrier Specialist

If you’ve taken probiotics before — from the pharmacy or just yogurt with billions of live cultures — they probably helped temporarily. But generic probiotics can’t rebuild your gut lining. That requires a different kind of organism.

Akkermansia muciniphila lives specifically in the mucus layer of your intestines and strengthens the protective barrier between your gut and bloodstream. It should make up 1–4% of a healthy microbiome. A January 2026 study (Ou et al.) showed pasteurized Akkermansia improved survival, mobility, learning, and memory in aged animal models. A 2026 review (Vorontsov et al.) confirmed that people with low Akkermansia have higher systemic inflammation, worse glucose metabolism, and weaker gut barrier function.

When Akkermansia drops below 1%, gut barrier integrity declines. Bacterial fragments leak into the bloodstream. The immune system responds with inflammation. The downstream effects — fatigue, brain fog, metabolic sluggishness — are often attributed to aging when they are, in part, a measurable loss of a specific protective microbe.

Clinical trial data: A randomized trial by Depommier et al. (Nature Medicine) found three months of pasteurized Akkermansia improved insulin sensitivity by 28% and reduced fasting insulin levels in overweight adults.

How to support Akkermansia

Research points consistently to polyphenols as the primary dietary driver. Foods that support Akkermansia levels:

• Pomegranate and pomegranate extract
• Green tea (3–4 cups daily)
• Dark berries (blueberries, blackberries)
• Extra virgin olive oil
• Cacao

Fermentable fiber is also important substrate. In practice: 3–6 months of dietary changes produce measurable changes in Akkermansia levels. Not fast, but consistent. The converse is also true — ultra-processed diets deplete Akkermansia reliably and quickly.

SIBO: When Bacteria Colonize the Wrong Location

The small intestine is not supposed to be heavily colonized by bacteria. Its job is nutrient absorption, and that process requires a relatively clean environment. The large bacterial populations belong in the colon. When bacteria migrate upstream and multiply in the small intestine — a condition called SIBO (small intestine bacterial overgrowth) — the consequences are significant.

These bacteria produce enzymes that degrade the nutritional content of food before it can be absorbed. Fat-soluble vitamins (A, D, E, K) are particularly vulnerable. The bacteria also disrupt water and electrolyte absorption, producing loose stools and progressive dehydration if untreated. The result is malabsorption — patients eat adequately but become progressively malnourished.

The recognizable symptoms of SIBO:

• Bloating and abdominal distension, typically worse after meals
• Abdominal cramping
• Diarrhea or alternating bowel habits
• Unexpected weight loss despite normal intake
• Fatigue and micronutrient deficiencies

Diagnosis: SIBO is confirmed by breath testing (hydrogen and methane). If you have persistent bloating with no identified cause, this test is worth requesting — it is non-invasive and specific. The standard treatment is Rifaximin, an antibiotic that targets gut bacteria without systemic absorption, making it well-tolerated and effective for this indication.

The Best Probiotics for Metabolic Health

Probiotics are the beneficial bacteria and yeasts that make up your gut flora. They maintain normal digestion, prevent pathogen overgrowth, produce essential metabolites including butyrate, and regulate the immune response that originates in the gut. The question is not whether probiotics matter — they do — but which strains matter most for metabolic function.

The strains with the strongest clinical evidence for gut and metabolic health:

• Lactobacillus reuteri — reduces intestinal permeability and supports immune regulation
• Lactobacillus acidophilus — improves insulin sensitivity and supports glucose regulation
• Bifidobacterium lactis — reduces inflammatory markers and improves bowel regularity
• Lactobacillus rhamnosus — reduces gut inflammation and supports metabolic function
• Saccharomyces boulardii — a yeast probiotic with documented effects on gut inflammation, traveler’s diarrhea, and insulin resistance

Lactobacillus species are particularly well-studied for insulin regulation. When the cells of the body become desensitized to insulin — insulin resistance — blood glucose control deteriorates. Research shows probiotics from the Lactobacillus family reduce this resistance by improving gut barrier integrity and reducing the LPS burden that drives metabolic inflammation.

Saccharomyces boulardii: the yeast probiotic worth knowing

S. boulardii is not a bacterium — it is a yeast that functions as a probiotic. This distinction matters because it survives antibiotic treatment that would kill bacterial probiotics, making it particularly useful during or after antibiotic courses. Its documented medical uses include reducing gut inflammation, protecting against traveler’s diarrhea, improving lipid metabolism, and showing benefit in non-alcoholic fatty liver disease. It is the only probiotic with documented effects on obesity through direct fat metabolism pathways, at a standard dose of 250 mg twice daily.

One caution: S. boulardii is contraindicated in immunocompromised patients, where it carries risk of fungemia. Confirm with a physician before using if you are on immunosuppressive therapy.

What causes probiotic deficiency

The most common disruptors of the gut flora are:

• Antibiotic courses (even a single course disrupts the microbiome for months)
• Chronic psychological stress
• Ultra-processed and canned food diets
• Excess refined sugar

Testing and Next Steps

Most of what I’ve described here is measurable. A comprehensive microbiome analysis identifies your Akkermansia levels, butyrate-producing bacteria abundance, LPS-producing organism load, and overall diversity score. That data tells us what’s depleted, what’s overgrown, and where the leverage is — rather than guessing with generic probiotics.

The patients who get the most out of microbiome optimization are those who test first, intervene based on results, and retest at 3–6 months. The biology responds. It just requires knowing what you’re working with.

If you want to understand what’s happening in your gut — rather than treating symptoms blind — the microbiome gut health test is where to start. We analyze the results and give you a specific protocol based on what we find.

References: Rifaximin for SIBO (PMC3099351) · Butyrate: extraintestinal and intestinal effects (PMC3070119) · Saccharomyces boulardii clinical uses (PMID 34444671) · Depommier C et al. (2019) Nature Medicine 25(7):1096-1103 · Ou Y et al. (2026) Functional Foods in Health and Disease 16(1):29-41 · Vorontsov AI et al. (2026) Frontiers in Immunology 16 · LPS and gut inflammation · Elevated LPS and disease associations (PMC3562736)